Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia

Leuk Lymphoma. 2012 Mar;53(3):497-8. doi: 10.3109/10428194.2011.615425. Epub 2011 Sep 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Chromatography, High Pressure Liquid
  • Chromosomes, Human, Pair 8 / genetics*
  • Clone Cells / metabolism
  • Clone Cells / pathology
  • DNA Mutational Analysis
  • Dasatinib
  • Genomic Instability*
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myeloid, Chronic-Phase / drug therapy
  • Leukemia, Myeloid, Chronic-Phase / genetics*
  • Leukemia, Myeloid, Chronic-Phase / pathology
  • Male
  • Middle Aged
  • Molecular Targeted Therapy
  • Philadelphia Chromosome*
  • Piperazines / therapeutic use*
  • Preleukemia / genetics
  • Preleukemia / pathology
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Real-Time Polymerase Chain Reaction
  • Selection, Genetic
  • Thiazoles / therapeutic use
  • Trisomy*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Dasatinib